Cardiac Simulator for Surgical Planning
Utilizing a Multi-Physics Cardiac Simulator for Surgical Planning in Complex Congenital Heart Disease Pediatric Patients
2 other identifiers
interventional
275
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn if a computer software program (cardiac simulator) for surgical planning will lead to improvements in patient care by decreasing the incidence of unsuccessful interventions and reinterventions for pediatric patients with congenital heart disease. It is not a commercially available device to treat congenital heart disease in pediatric patients. The main aims are: To provide safe pre-operative testing of surgical approaches with a computer model cardiac simulator. To aid surgeons in envisioning different surgical approaches for each individual patient. To bolster the standard of care surgical planning discussions which will be particularly useful for patients with unique, complex congenital heart disease. Participants will: Consent to being randomized with a 50% chance of receiving standard of care "on the fly" surgical planning discussion as is current practice or assisted surgical planning discussion with the aid of the computer software cardiac simulator. Receive results of their computer simulated findings during their surgical planning discussion if they are in the cardiac simulator group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2024
CompletedFirst Posted
Study publicly available on registry
April 18, 2024
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2029
April 22, 2024
April 1, 2024
3 years
April 16, 2024
April 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality
Alive or deceased post-operative
At date of hospital discharge or up to 30 days post-operation
Secondary Outcomes (2)
Mortality
Latest follow-up exam up to 3 years post-operation
Number of cardioplegic arrest
Up to 10 hours
Other Outcomes (10)
Number of repair revisions needed
At date of hospital discharge or up to 30 days post-operation
Time on cardiopulmonary bypass
Up to approximately 10 hours intra-operation
Ventricular function
Immediately post-operation, at date of discharge, follow-up to 3 years
- +7 more other outcomes
Study Arms (2)
Conventional surgical planning discussion without cardiac simulator
NO INTERVENTIONConventional surgical planning discussion without cardiac simulator
Surgical planning discussion with aid of cardiac simulator
EXPERIMENTALSurgical planning discussion with aid of cardiac simulator
Interventions
A computer software cardiac simulator for surgical planning in complex Congenital Heart Disease (CHD) pediatric patients.
Eligibility Criteria
You may not qualify if:
- Adult patients with CHD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- National Institutes of Health (NIH)collaborator
Study Officials
- PRINCIPAL INVESTIGATOR
Alison Marsden, PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- After consent to participate in the study, patient will be entered into a random allocation sequence for standard of care (SOC) or cardiac simulator groups. Patient and surgeon will both be notified which group they have been assigned to.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DOUGLASS M. AND NOLA LEISHMAN PROFESSOR OF CARDIOVASCULAR DISEASES, PROFESSOR OF PEDIATRICS (CARDIOLOGY) AND OF BIOENGINEERING AND, BY COURTESY, OF MECHANICAL ENGINEERING
Study Record Dates
First Submitted
April 16, 2024
First Posted
April 18, 2024
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2029
Study Completion (Estimated)
April 1, 2029
Last Updated
April 22, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share